Back to Conditions

Dolutegravir: Modern HIV Treatment Explained

Dolutegravir: Modern HIV Treatment Explained
Prescription Medicines Editorial 22 February 2026

Dolutegravir is an integrase inhibitor - it blocks the enzyme HIV uses to insert its genetic material into human DNA. It is a cornerstone of modern HIV treatment, usually combined with one or two other drugs in a single daily tablet. Modern treatment works well enough that two statements which once sounded optimistic are now simply accurate: people diagnosed and treated promptly have a near-normal life expectancy, and someone with a sustained undetectable viral load cannot pass HIV on sexually.

Follow the plan your HIV team gave you. This guide contains no doses.

Undetectable equals untransmittable

Large studies following thousands of couples where one partner had HIV and an undetectable viral load recorded no transmissions through sex.

The evidence is strong enough that U=U is accepted internationally. It requires a sustained undetectable viral load, which means taking treatment consistently and attending monitoring - not simply being on medication.

It matters beyond transmission: it is one of the most effective things available against the stigma that still surrounds an HIV diagnosis.

Why adherence matters more here

HIV replicates rapidly and mutates constantly. If drug levels drop, the virus can replicate in the presence of enough drug to select for resistant variants - but not enough to suppress them.

Resistance, once it develops, is permanent. It narrows the options for the rest of your life.

Dolutegravir has a relatively high barrier to resistance compared with older drugs, which is one reason it is favoured. That is not a reason to be casual. If you are struggling to take it consistently, tell your team - they deal with this constantly and there are practical answers, including long-acting injectable options given every couple of months.

Indigestion remedies and supplements

This is the interaction people fall over, because the culprits are bought casually and not thought of as medicines.

Antacids, and supplements containing magnesium, aluminium, calcium or iron, bind dolutegravir in the gut and substantially reduce absorption - enough to risk treatment failure.

They must be separated: dolutegravir taken well before, or several hours after. Check the exact intervals for your product, since they differ, and taking it with food changes the advice for some combinations.

See medicines, milk and dairy and over-the-counter interactions. Multivitamins are the commonest hidden source.

Other interactions

Dolutegravir raises metformin levels, so the metformin dose may need adjusting - see metformin.

Enzyme inducers reduce dolutegravir levels - rifampicin, carbamazepine, some other anticonvulsants, and St John's wort, which should not be taken with HIV treatment at all. See carbamazepine and supplements that interfere with your medicines.

Tell every prescriber, dentist and pharmacist that you take HIV medication, and check any new medicine - including anything bought over the counter. HIV drug interaction checkers are freely available online and your HIV pharmacist will check for you.

Side effects

Dolutegravir is generally well tolerated. Headache, nausea, diarrhoea and insomnia are the common early effects and usually settle.

Sleep disturbance and mood changes - insomnia, vivid dreams, anxiety, low mood - are reported and are worth mentioning rather than enduring, since switching within the class is often possible.

Weight gain is recognised with integrase inhibitors, particularly in combination with tenofovir alafenamide, and can be substantial. It is an active area of research and a legitimate thing to raise at review - see medicines and your weight.

A small rise in creatinine occurs early and reflects a change in how creatinine is handled rather than kidney damage. It is expected and does not mean the kidneys are failing.

Seek urgent advice for rash with fever, or jaundice, dark urine and abdominal pain - hypersensitivity and liver reactions are rare but recognised.

Pregnancy

An early signal suggesting a possible increase in neural tube defects with dolutegravir at conception prompted caution for a period. Subsequent larger data found the risk was much smaller than first reported, and dolutegravir is now recommended in pregnancy in many settings.

It remains a discussion to have with your HIV team if you are planning a pregnancy, along with higher-dose folic acid - see folic acid.

Long-acting injections

Injectable treatment given every one or two months is now an option for some people with a suppressed viral load, replacing daily tablets. Cabotegravir, a related integrase inhibitor, is used this way alongside rilpivirine.

It suits people who find daily tablets difficult, or for whom keeping medication at home creates a privacy problem. It requires attending for injections on schedule, which is its own form of adherence, and it is not suitable for everyone - resistance history and other medicines both matter.

Monitoring

Viral load and CD4 count are checked regularly, along with kidney and liver function, lipids and glucose.

Cardiovascular risk, bone health and cancer screening all matter more as people with HIV live normal lifespans - see monitoring long-term medicines.

HIV treatment is free in the UK regardless of immigration status, and so is testing.

The Conditions section covers more on what medicines are prescribed for - Anastrozole: How It Differs From Tamoxifen is closely related to this one.